Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
644 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2022-06-09 | 2022-07-12 | 162343 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-05-19 | 2019-03-09 | 10718 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Actual shortage | 2019-03-13 | 2020-04-23 | 78454 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-05-22 | 2019-06-19 | 84515 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-17 | 2019-09-26 | 94099 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-02-05 | 2021-03-17 | 133432 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| GEN-CLOZAPINE | 200MG | TABLET | Resolved | 2017-03-23 | 2017-11-15 | 4063 |
| GEN-CLOZAPINE | 50MG | TABLET | Resolved | 2017-10-10 | 2017-10-21 | 24836 |
| GEN-CLOZAPINE | 100MG | TABLET | Avoided shortage | 2017-11-03 | 2017-11-23 | 28038 |
| MYLAN-LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-20 | 2019-09-18 | 91964 |
| MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ACEBUTOLOL (TYPE S) | 100MG | TABLET | Discontinued | 2017-08-24 | 2018-02-15 | 20275 |
| MYLAN-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20309 |
| MYLAN-ACEBUTOLOL | 200MG | TABLET | Discontinued | 2017-11-23 | 2018-07-04 | 30374 |
| MYLAN-ACEBUTOLOL | 100MG | TABLET | Discontinued | 2018-06-12 | 2018-07-04 | 52262 |
| MYL-SILDENAFIL | 100MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16057 |
| MYL-SILDENAFIL | 25MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16172 |
| MYL-SILDENAFIL | 50MG | TABLET | Discontinued | 2017-07-18 | 2018-05-02 | 16175 |
| MYL-PROPAFENONE | 150MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41530 |
| MYL-PROPAFENONE | 300MG | TABLET | Discontinued | 2018-03-02 | 2018-03-02 | 41533 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| ESME 28 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53722 |
| ESME 21 | 20MCG 100MCG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53714 |
| AZITHROMYCIN FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-07-17 | 2018-02-15 | 15804 |